ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions

Pregnancy induces notable alterations in the gut, vaginal, and oral microbiota driven by hormonal, immune, metabolic, dietary, and environmental factors. During pregnancy, the gut microbiota is characterized by increased proportions of the genus Bifidobacterium and the phyla Pseudomonadota (formerly...

Full description

Saved in:
Bibliographic Details
Main Authors: Eduard Flores Ventura, Jonathan A. Lane, Sondra Turjeman, Nikoletta Vidra, Gisela Adrienne Weiss, Gabriele Gross, Ching-Yu Chang, Omry Koren
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2025.2501186
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849716326687309824
author Eduard Flores Ventura
Jonathan A. Lane
Sondra Turjeman
Nikoletta Vidra
Gisela Adrienne Weiss
Gabriele Gross
Ching-Yu Chang
Omry Koren
author_facet Eduard Flores Ventura
Jonathan A. Lane
Sondra Turjeman
Nikoletta Vidra
Gisela Adrienne Weiss
Gabriele Gross
Ching-Yu Chang
Omry Koren
author_sort Eduard Flores Ventura
collection DOAJ
description Pregnancy induces notable alterations in the gut, vaginal, and oral microbiota driven by hormonal, immune, metabolic, dietary, and environmental factors. During pregnancy, the gut microbiota is characterized by increased proportions of the genus Bifidobacterium and the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria). These changes occur alongside reduced alpha diversity and greater beta diversity, changes that influence maternal metabolism and fetal development. Shifts in gut and oral microbiota have been associated with complications such as preterm birth (PTB), pre-eclampsia, and gestational diabetes (GDM), though patterns are sometimes inconsistent. The vaginal microbiota remains Lactobacillus-dominant during pregnancy, with reduced diversity leading to reduced risk of pathogenic infection and increased diversity has been linked with a higher risk of PTB. Hormonal changes also affect the oral microbiota, potentially increasing pathogenic species and contributing to adverse outcomes like PTB. Probiotic supplementation during pregnancy has significant potential to reduce adverse pregnancy outcomes; however, clinical studies are still limited. Probiotics may be effective in alleviating maternal constipation and lead to lower PTB risk, particularly by modulating the vaginal microbiota, but they have limited impact on GDM. In the context of maternal mental health, some studies suggest benefits of probiotics in reducing anxiety, but effects on depression are inconclusive. This perspective examines how pregnancy-related microbial shifts, both natural and probiotic-induced, affect maternal and fetal health and highlights potential opportunities for the innovative use of probiotics during the gestation period.
format Article
id doaj-art-1dc97a3dfbe34d1682d4e6c0ccfda8fe
institution DOAJ
issn 1949-0976
1949-0984
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Gut Microbes
spelling doaj-art-1dc97a3dfbe34d1682d4e6c0ccfda8fe2025-08-20T03:13:03ZengTaylor & Francis GroupGut Microbes1949-09761949-09842025-12-0117110.1080/19490976.2025.2501186ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventionsEduard Flores Ventura0Jonathan A. Lane1Sondra Turjeman2Nikoletta Vidra3Gisela Adrienne Weiss4Gabriele Gross5Ching-Yu Chang6Omry Koren7Department of Biotechnology, Institute of Agrochemistry and Food Technology – Spanish National Research Council (IATA-CSIC), Valencia, SpainHealth and Happiness (H & H) Group, H & H Research, National Food Innovation Hub, Teagasc Moorepark, Fermoy, Co., Cork, IrelandAzrieli Faculty of Medicine, Bar-Ilan University, Safed, IsraelScience Department, Yakult Europe, Almere, The NetherlandsDepartment Innovation, Yili Innovation Center Europe, Wageningen, The NetherlandsMead Johnson Nutrition Institute/Reckitt, R & D, Nutrition Science Platforms, Nijmegen, The NetherlandsInternational Life Science Institute, International Life Science Institute, European Branch, Brussels, BelgiumAzrieli Faculty of Medicine, Bar-Ilan University, Safed, IsraelPregnancy induces notable alterations in the gut, vaginal, and oral microbiota driven by hormonal, immune, metabolic, dietary, and environmental factors. During pregnancy, the gut microbiota is characterized by increased proportions of the genus Bifidobacterium and the phyla Pseudomonadota (formerly Proteobacteria) and Actinomycetota (formerly Actinobacteria). These changes occur alongside reduced alpha diversity and greater beta diversity, changes that influence maternal metabolism and fetal development. Shifts in gut and oral microbiota have been associated with complications such as preterm birth (PTB), pre-eclampsia, and gestational diabetes (GDM), though patterns are sometimes inconsistent. The vaginal microbiota remains Lactobacillus-dominant during pregnancy, with reduced diversity leading to reduced risk of pathogenic infection and increased diversity has been linked with a higher risk of PTB. Hormonal changes also affect the oral microbiota, potentially increasing pathogenic species and contributing to adverse outcomes like PTB. Probiotic supplementation during pregnancy has significant potential to reduce adverse pregnancy outcomes; however, clinical studies are still limited. Probiotics may be effective in alleviating maternal constipation and lead to lower PTB risk, particularly by modulating the vaginal microbiota, but they have limited impact on GDM. In the context of maternal mental health, some studies suggest benefits of probiotics in reducing anxiety, but effects on depression are inconclusive. This perspective examines how pregnancy-related microbial shifts, both natural and probiotic-induced, affect maternal and fetal health and highlights potential opportunities for the innovative use of probiotics during the gestation period.https://www.tandfonline.com/doi/10.1080/19490976.2025.2501186Maternal healthprobioticspregnancygut microbiotaoral microbiotavaginal microbiota
spellingShingle Eduard Flores Ventura
Jonathan A. Lane
Sondra Turjeman
Nikoletta Vidra
Gisela Adrienne Weiss
Gabriele Gross
Ching-Yu Chang
Omry Koren
ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
Gut Microbes
Maternal health
probiotics
pregnancy
gut microbiota
oral microbiota
vaginal microbiota
title ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
title_full ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
title_fullStr ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
title_full_unstemmed ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
title_short ILSI Europe perspective review: site-specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes: opportunities for probiotic interventions
title_sort ilsi europe perspective review site specific microbiota changes during pregnancy associated with biological consequences and clinical outcomes opportunities for probiotic interventions
topic Maternal health
probiotics
pregnancy
gut microbiota
oral microbiota
vaginal microbiota
url https://www.tandfonline.com/doi/10.1080/19490976.2025.2501186
work_keys_str_mv AT eduardfloresventura ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT jonathanalane ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT sondraturjeman ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT nikolettavidra ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT giselaadrienneweiss ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT gabrielegross ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT chingyuchang ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions
AT omrykoren ilsieuropeperspectivereviewsitespecificmicrobiotachangesduringpregnancyassociatedwithbiologicalconsequencesandclinicaloutcomesopportunitiesforprobioticinterventions